Search

everythinglearnresearchcommunity

for

Search:↓

Individuals with this condition often develop male traits and identities at puberty despite being raised as females.

The new compounds may be more effective and cheaper than current treatments for conditions like baldness.

The conclusion is that new plant-based treatments for hair loss may work by targeting certain enzymes.

The body's change of testosterone into DHT is not necessary for testosterone's muscle and sexual effects.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

No significant hormone differences found in postmenopausal women with androgenetic alopecia.

Norethisterone (jenapharm) therapy is effective for endometrial cancer.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

Epristeride's metabolism involves key metabolites and proteins, affecting its use in doping tests.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

Acne severity is linked to higher levels of certain androgenic hormones, even when those levels are within the normal range.

New compounds were made that block an enzyme linked to breast cancer better than existing treatments.

Different halogens on progesterone derivatives can either block or mimic male hormone effects, depending on their type and amount.

Human skin can produce steroids from cholesterol.

5α-reductase enzymes are crucial in certain disorders, and while treatment advances exist, more research on SRD5A3 is needed.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

5α-reductases increase epitestosterone's effect on androgen receptors.

Aldactone was more effective in reducing hair growth in women with hirsutism than Diane, despite having less impact on hormone levels.

Low-dose oral contraceptives reduced hair growth and testosterone levels in women with polycystic ovary syndrome.

Spironolactone reduces the enzyme activity that converts testosterone to DHT, helping treat excessive hair growth in women.

Phytosterols may help manage prostate issues but are less effective than synthetic drugs.

Spironolactone treatment reduced hair growth and androgen levels in hirsute women, but the overall effectiveness was just adequate.

Testosterone affects androgen receptors and lipid storage in cells, while DHEA does not convert to testosterone or affect these receptors in the same way.

Higher DHEA-S levels are linked to smaller ovarian volume in women with PCOS.

The enzyme 5α-reductase type 1 is important for blood vessel development and fertility in the uterus.

Adolescents with PCOS have higher levels of certain androgens, which are linked to hair growth but don't help diagnose PCOS better than testosterone levels.

Steroid sulfatase inhibitors could help treat hormone-related disorders and cancers.

Glucocorticoids and sex hormones affect skin health, with potential for targeted treatments to minimize side effects and treat skin conditions.

Antiandrogens and finasteride may help treat excess hair and hair loss in women.

The patient likely has Chrousos syndrome, a rare condition causing insensitivity to glucocorticoids, requiring high-dose dexamethasone treatment.